We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+13.29%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$47.2B
AUM Growth
+$8.08B
(+21%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.95%
Top 10 Holdings %
Top 10 Hldgs %
35.89%
Holding
5,834
New
1,032
Increased
1,743
Reduced
1,554
Closed
961
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$376M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$115M |
| 3 |
Lam Research
LRCX
|
+$51.4M |
| 4 |
Crown Castle
CCI
|
+$45.4M |
| 5 |
Wyndham Hotels & Resorts
WH
|
+$43.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$59.4M |
| 2 |
VMW
VMware, Inc
VMW
|
+$57.2M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$52.6M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$48M |
| 5 |
Microsoft
MSFT
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.27% |
| 2 | Financials | 2.09% |
| 3 | Healthcare | 1.72% |
| 4 | Consumer Discretionary | 1.48% |
| 5 | Industrials | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Tango Therapeutics
TNGX
$4.43B
| $219K | ﹤0.01% |
+22,162
| New | +$192K |
|
3552
CALL
Gentex
GNTX
$4.97B
| $219K | ﹤0.01% |
6,700
-2,500
| -27% | -$77.2K |
|
3553
PUT
Immunocore
IMCR
$1.72B
| $219K | ﹤0.01% |
3,200
+1,300
| +68% | +$67.6K |
|
|
SA
3554
Seabridge Gold
SA
$2.78B
| $217K | ﹤0.01% |
17,909
-7,566
| -30% | -$87K |
|
3555
CALL
Ingredion
INGR
$6.27B
| $217K | ﹤0.01% |
+2,000
| New | +$201K |
|
3556
PUT
Cognex
CGNX
$10.9B
| $217K | ﹤0.01% |
5,200
| – | – |
|
3557
REX American Resources
REX
$1.42B
| $217K | ﹤0.01% |
+9,172
| New | +$183K |
|
3558
PUT
Guardant Health
GH
$21.7B
| $216K | ﹤0.01% |
8,000
-3,800
| -32% | -$99.7K |
|
3559
SES AI Corp Warrants
SES.WS
$3.14M
| $214K | ﹤0.01% |
1,239,470
+31,595
| +3% | +$5.67K |
|
3560
CALL
Workiva
WK
$3.36B
| $213K | ﹤0.01% |
2,100
-800
| -28% | -$77.2K |
|
3561
Flowers Foods
FLO
$1.49B
| $213K | ﹤0.01% |
9,458
-5,922
| -39% | -$128K |
|
3562
CALL
Braze
BRZE
$2.81B
| $213K | ﹤0.01% |
4,000
+1,300
| +48% | +$64.3K |
|
3563
Blackbaud
BLKB
$1.94B
| $212K | ﹤0.01% |
+2,441
| New | +$185K |
|
3564
PUT
Zumiez
ZUMZ
$332M
| $212K | ﹤0.01% |
10,400
+1,100
| +12% | +$19.7K |
|
3565
Lifestance Health
LFST
$4B
| $212K | ﹤0.01% |
+27,014
| New | +$174K |
|
3566
PUT
Liberty Global Class A
LBTYA
$3.62B
| $210K | ﹤0.01% |
11,800
+6,200
| +111% | +$100K |
|
3567
CALL
AMN Healthcare
AMN
$1.3B
| $210K | ﹤0.01% |
2,800
-70,500
| -96% | -$5.04M |
|
|
3568
CALL
Flowers Foods
FLO
$1.49B
| $209K | ﹤0.01% |
+9,300
| New | +$201K |
|
3569
Genco Shipping & Trading
GNK
$1.11B
| $209K | ﹤0.01% |
+12,617
| New | +$183K |
|
|
3570
PUT
Gentex
GNTX
$4.97B
| $209K | ﹤0.01% |
+6,400
| New | +$198K |
|
3571
PUT
US Foods
USFD
$22.2B
| $209K | ﹤0.01% |
4,600
+2,700
| +142% | +$112K |
|
|
AFAR
3572
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
| $209K | ﹤0.01% |
19,200
| – | – |
|
3573
PUT
RadNet
RDNT
$5.02B
| $209K | ﹤0.01% |
6,000
+1,400
| +30% | +$44.2K |
|
3574
CALL
Polaris
PII
$3.82B
| $208K | ﹤0.01% |
2,200
-1,900
| -46% | -$174K |
|
3575
CALL
Playtika
PLTK
$1.52B
| $208K | ﹤0.01% |
23,900
-100
| -0.4% | -$869 |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Walleye Capital held 5,834 positions worth $47.2B, up 21% from $39.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Walleye Capital deployed $2.33B of net new capital in Q4 2023, opening 1,032 new positions and adding to 1,743 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $59.4M trimmed.
- Walleye Capital's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
- Walleye Capital added most to Lam Research in Q4 2023, an estimated $51.4M increase.
- Walleye Capital's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $59.4M.
- Walleye Capital fully exited VMware, Inc in Q4 2023, selling an estimated $57.2M.
- Walleye Capital's ten largest holdings make up 36% of its $47.2B portfolio in Q4 2023.
- Walleye Capital opened 1,032 new positions and closed 961 in Q4 2023.
- Walleye Capital's portfolio value rose 21% quarter-over-quarter to $47.2B.
Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.